TITLE :Profile and outcome of very low birth weight (VLBW) infants - - PowerPoint PPT Presentation

title profile and outcome of very low birth weight
SMART_READER_LITE
LIVE PREVIEW

TITLE :Profile and outcome of very low birth weight (VLBW) infants - - PowerPoint PPT Presentation

TITLE :Profile and outcome of very low birth weight (VLBW) infants at a public health tertiary care NICU in North India Yogesha K N , Sushma Nangia, Debasish Nanda, Department of Neonatology, Lady Hardinge Medical College, New Delhi Background


slide-1
SLIDE 1

TITLE :Profile and outcome of very low birth weight (VLBW) infants at a public health tertiary care NICU in North India Yogesha K N, Sushma Nangia, Debasish Nanda, Department of Neonatology, Lady Hardinge Medical College, New Delhi

slide-2
SLIDE 2

Background

  • In recent WHO report, approximately 2.9

million neonates die annually in the world.

  • Complications of prematurity is one the

leading cause for neonatal death

  • About 15million premature births in the world

and a million of children die each year due to complications of preterm birth

WHO report 2014 Born Too Soon The Global Action Report on Preterm Birth 2012

slide-3
SLIDE 3

Background

  • WHO defines Very low birth weight babies (VLBW) as

birth weight < 1500 grams at birth irrespective of gestational age.

  • The incidence of VLBW babies is less than 2% of the

births globally.

  • In India, VLBW babies constitute 4% to 7% of the live

births and approximately 30% of neonatal death

National Neonatal Perinatal Database Network. National Neonatology Forum of India; 2004. Eichenwald EC, Stark AR. N Engl J Med. 2008

slide-4
SLIDE 4

Advances in neonatal care like, 1. Antenatal corticosteroids(ANS) 2. CPAP 3. Other modes of non invasive ventilation 4. Surfactant therapy 5. Gentle mechanical ventilation 6. Better understanding of disease process 7. Early enteral nutrition has resulted in improved survival of VLBW infants. Data related to survival and morbidity profile of VLBW infants is largely from high income countries. Similar data from LMICs is limited

Eichenwald EC, Stark AR. N Engl J Med. 2008

  • S. Murki et al. Indian J Pediatr 2015

Background

slide-5
SLIDE 5

Objective

To evaluate the clinical profile of VLBW infants from a tertiary care NICU of a public health Institution from North India

slide-6
SLIDE 6

Study design

Type of study : Prospective observational study Place of study : Nursery of Smt Sucheta Kriplani Hospital

and Neonatal ward of Kalawati Saran Children’s Hospital & Lady Hardinge Medical College–a tertiary care centre with facility for ventilation and care of sick neonates.

Duration of study : 24 months (Jan 2016 to Dec 2018) Study Subjects : All neonates with birth weight less than

1500gm.

slide-7
SLIDE 7

Inclusion criteria

All neonates of gestational age(GA) less than 1500gms will be enrolled

Exclusion criteria

  • Major congenital malformation
  • Gestation less than 25 weeks
  • Refusal for consent
slide-8
SLIDE 8

End point of the study

The subject will be followed up to

  • Discharge from the hospital
  • Death
slide-9
SLIDE 9

Results

  • Out of 25782 live births during the study period,

944 (3.7%) infants were VLBW and were admitted to the NICU.

  • Mean gestation age was 30+3 (24-39) weeks with

90% below 34 weeks and mean birth weight was 1157+327 (500-1498) gm.

slide-10
SLIDE 10
  • Overall(VLBW) survival was 84.2%, its in consistent with developed

country study by Eric C. Eichenwald et al (survival is 84%)

  • Study from India showed, the neonatal mortality rate till discharge

was 15.7% in VLBW group and 33.3% in ELBW group.

  • In S Murki et al study VLBW survival is 88%.
  • About 70.5% survival in south african study

Roy KK. Indian J Pediatr. 2006

  • S. Murki et al. Indian J Pediatr 2015

Daynia E Ballot BMC Pediatrics2010

Results

slide-11
SLIDE 11
  • Partial/complete course of antenatal

corticosteroids was received by 68% mothers.

  • About a third of the infants had one or more

antenatal risk factors for early onset sepsis.

  • Around 23% (213) required surfactant

therapy with 76% receiving it by INSURE technique.

Results

slide-12
SLIDE 12

Baseline Characteristics Gestational age (Weeks) (Mean±SD) 30.7±2.89weeks ( 24.0-39.0) Birth weight (Grams) (Mean±SD) 1157+327 (500-1498) Male (%) 526(55.72%) Antenatal steroid (%) 636(68.0%) Cesarean delivery (%) 330(34.99%) Perinatal asphyxia (5 min APGAR ≤ 6) 151(16.07%) Duration of rupture of membrane >24 h 331(35%)

Baseline Characteristics

slide-13
SLIDE 13

Survival according gestational

0.2 0.4 0.6 0.8 1 1.2 ≤ 27 28-29 30-31 32-34 ≥35

Survival(%)

slide-14
SLIDE 14

Causes for mortality

Sepsis IVH (grade ≥ 3) NEC Extreme prematurity

slide-15
SLIDE 15

Outcomes

Most common morbidity was sepsis (46.6%) followed by RDS (42%), it is consisted with many studies conducted in LMIC but RDS is most common morbidity in developed countries .

Roy KK. Indian J Pediatr. 2006

  • S. Murki et al. Indian J Pediatr 2015

Daynia E Ballot BMC Pediatrics2010 Eichenwald EC . N Engl J Med. 2008

slide-16
SLIDE 16

Morbidity Number

Percentage Sepsis 439 46.6% Meningitis 57 6.0% RDS 396 42% Air leak 12 1.3% HsPDA 49 5.2% IVH(any grade) 94 10% IVH ≥ grade 3 19 2.0% NEC ( any stage) 69 7.3% NEC stage ≥ 2 21 2.2% BPD 33 3.5% ROP 49 5.2%

Outcomes

slide-17
SLIDE 17
  • Blood culture positivity was detected in 13.1%
  • f sepsis cases
  • Klebsiella spp. being the commonest isolate

(35%) followed by Staphylococcus aureus (20%), it is consisted with Indian data

  • Meningitis was diagnosed in 6% cases.

National Neonatal Perinatal Database Network National Neonatology Forum of India; 2004

Outcomes

slide-18
SLIDE 18
  • Ten percent developed any grade of IVH with

2% having severe IVH (IVH grade ≥ 3),

  • More than 2% (2.2%) developed NEC stage 2
  • r higher
  • Any stage ROP was identified in nearly 5.2%

and 2.6% required treatment

Outcomes

slide-19
SLIDE 19
  • Additionally, 5.2% had HsPDA requiring

pharmacologic closure, 1.3% developed airleak

  • Three percent of the cases required
  • xygen(O2) therapy beyond 28 days of life and
  • nly 1/4th of these continued to require O2

beyond 36 wks PMA

Outcomes

slide-20
SLIDE 20

Thank You